Albany, NY, United States of America

Michael Conlon

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 8.0

ph-index = 7

Forward Citations = 129(Granted Patents)


Location History:

  • Albany, NY (US) (2016 - 2020)
  • Schenectady, NY (US) (2019 - 2024)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael Conlon

Introduction

Michael Conlon is an esteemed inventor based in Albany, NY, with a significant record of innovation that includes 16 patents to his name. His notable work focuses primarily on chemical compounds, and his latest inventions promise advancements in pharmaceutical applications.

Latest Patents

Among Conlon's most recent patents are his innovations in the field of 4-phenylpiperidines. This includes a compound with a specific structure and its preparation and use. These inventions also encompass pharmaceutically acceptable salts, highlighting both versatility and applicability in medical settings.

Career Highlights

Conlon has achieved notable recognition for his contributions while working at Columbia University. His role at this prestigious institution has allowed him to push the boundaries of scientific research and apply his inventive mindset to practical solutions.

Collaborations

Throughout his career, Conlon has collaborated with talented individuals such as Konstantin Petrukhin and Christopher Cioffi. This teamwork emphasizes the importance of collaboration in the field of innovation, as it often leads to new ideas and breakthroughs.

Conclusion

In conclusion, Michael Conlon stands out as a prominent inventor whose work continues to influence the field of chemistry and pharmaceuticals. With 16 patents to his credit, his innovative spirit and collaboration with peers solidify his status as an important figure in the realm of invention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…